Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in treating atherosclerosis and cardiovascular disease

Patent metadata

Field	Value
Publication number	US-11000564-B2
Application number	US-201815898477-A
Country	US
Kind code	B2
Filing date	Feb 17, 2018
Priority date	Jan 7, 2010
Publication date	May 11, 2021
Grant date	May 11, 2021

Abstract

A composition comprising extracts containing oil palm phenolics in an amount effective for use in a method of reducing cholesterol biosynthesis and thus preventing obesity. The composition up regulates fatty acid beta oxidation and down regulates cholesterol biosynthesis in livers. The composition is useful for prevention of obesity associated diseases. The composition delays the onset of obesity and attenuates the inflammatory response of atherogenic diet, whereby the composition aids to suppress the inflammatory response thereby ameliorating artherosclerosis. The composition delays weight gain or obesity thereby preventing the effects of dyslipidemia.

First claim

We claim:

1. A method of treating atherosclerosis and cardiovascular disease by preventing obesity and reducing cholesterol biosynthesis in a patient in need thereof, by up-regulating fatty acid beta oxidation genes, and down-regulating five cholesterol biosynthesis genes in the patient said genes are lanosterol synthase (Lss), sterol-C4-methyl oxidase-like (Sc4mol), farnesyl diphosphate synthetase (Fdps), NAD(P) dependent steroid dehydrogenase-like (Nsdhl) and 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (Hmgcs1); the method comprising administering an extracts comprising oil palm phenolics obtained from oil palm vegetation liquor; wherein a concentration of antioxidant in the extract comprising oil palm phenolics is 1500 gallic acid equivalent.

2. The method as claimed in claim 1 , wherein the extract comprising oil palm phenolics is provided in solid dosage, liquid dosage or solution form.

3. The method as claimed in claim 1 wherein the extract comprising oil palm phenolics in a pharmaceutically effective form.

4. The method as claimed in claim 1 wherein the extract comprising oil palm phenolics is provided in a nutraceutical or nutraceutical nutritional supplementary form.

5. The method as claimed in claim 1 wherein the extract comprising oil palm phenolics is provided in a form suitable for oral administration.

6. The method as claimed in claim 1 , wherein the extract comprising oil palm phenolics up regulates fatty acid beta oxidation and down regulates cholesterol biosynthesis in livers of the patient.

7. The method as claimed in claim in 1 , wherein the extract comprising oil palm phenolics delays an onset of obesity and attenuates inflammatory response of an atherogenic diet, whereby the extract comprising oil palm phenolics aids to suppress inflammatory response thereby ameliorating atherosclerosis.

8. The method as claimed in claim in 1 , wherein the extract comprising oil palm phenolics delays weight gain or obesity in the patient thereby preventing the effects of dyslipidemia.

9. The method as claimed in claim in 1 , wherein the extract comprising oil palm phenolics is further useful in suppression of liver fat and visceral fat accumulation by way of up-regulating the fatty acid beta oxidation.

10. The method as claimed in claim in 1 , wherein the extract comprising oil palm phenolics is further useful in preventing alcohol-induced liver damage.

11. The method as claimed in claim in 1 , wherein the extract comprising oil palm phenolics is further useful in up-regulating unfolded protein response, thus eliminating the proteins that cannot be re-folded.

12. The method as claimed in claim in 1 , wherein the extract comprising oil palm phenolics is further useful in down-regulating antigen presentation.

13. The method as claimed in claim in 1 , wherein the extract comprising oil palm phenolics further useful in reducing damaged proteins caused by atherogenic diet.

14. The method as claimed in claim in 1 , wherein the extract comprising oil palm phenolics is obtained from any part of palm oil.

15. The method as claimed in claim in 1 , wherein the extract comprising oil palm phenolics is obtained from palm oil mill vegetation liquor.

Assignees

• Malaysian Palm Oil Board

Inventors

• Leow Soon Sen
• Sambanthamurthi Ravigadevi
• Tan Yew Ai
• P Manickam Kalyana Sundram
• Wahid Mohd Basri

Classifications

• A61K36/889 Primary

  Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto · CPC title

• A61P9/10

  for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title

• A61P3/06

  Antihyperlipidemics · CPC title

• A61K31/05

  Phenols {(cannabinoids A61K31/658)} · CPC title